A new website providing news and resources to the Oral Mucositis community is in the spotlight in the wake of Senator Edward M. Kennedy's death on August 25, 2009. The senator died after a year-plus battle with a malignant brain tumor.
The Oral Mucositis Newswire, launched earlier this month, surmises that prior to his death the senator suffered from oral mucositis, a side effect that impacts virtually all head and neck cancer patients who receive radiation and chemotherapy.
"I've undergone many rounds of chemotherapy and continue to receive treatment," Senator Kennedy wrote in a first-person article published in the July 27th edition of Newsweek magazine. The Massachusetts Democrat further disclosed that he had undergone proton-beam radiation therapy at Massachusetts General Hospital.
In a post titled, "In all probability, Senator Kennedy also suffered from Oral Mucositis," the Oral Mucositis Newswire notes "While Kennedy's illness calls attention to brain cancer and advances in its treatment, the degree to which the senator was impacted by oral mucositis remains a mystery."
The Oral Mucositis Newswire goes on to say that the annual incidents of oral mucositis in all cancer patients vastly outnumbers the number of brain cancer victims."
Oral Mucositis Newswire is written and published by TJFR Consulting Company, which provides strategic media relations consulting and related editorial services. One of TJFR's clients in the health field is Access Pharmaceuticals, a maker of an FDA-approved treatment for oral mucositis marketed as MuGard.
Comments